Article
The tubal epigenome - An emerging target for ovarian cancer.
Pharmacology & therapeutics - 1 Jun 2020
Reavis Hunter D, Drapkin Ronny
Abstract excerpt
Ovarian cancer is the most lethal gynecologic malignancy in the United States. The mortality of this disease is primarily attributed to challenges in early detection and therapeutic resistance. Recent studies indicate that the majority of high-grade serous ovarian carcinomas (HGSCs) originate from aberrant fallopian tube epithelial (FTE) cells. This shift in thinking about ovarian cancer pathogenesis has been met...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
